Akèy › Kansè pwostat › Kalifòni › Santa Monica
Etid klinik pou Kansè pwostat nan Santa Monica, CA
15 etid pou Kansè pwostat ap chèche patisipan nan sit nan ak bò kote Santa Monica (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
Ap rekriteFaz 2
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles · 4 mi lwen
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Ap rekriteFaz 3
- UCLA Hematology/Oncology- Santa Monica, Santa Monica
- UCLA Hematology/Oncology - Marina del Rey, Marina del Rey · 3 mi lwen
- Cedars-Sinai Cancer Beverly Hills (drug treatment and dispensing location), Beverly Hills · 6 mi lwen
- ak 3 plis
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Ap rekriteFaz 2/3
- Saint Johns Cancer Institute, Santa Monica
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Ap rekriteFaz 1
- University of California, Los Angeles (UCLA), Santa Monica
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Ap rekriteFaz 3
- Providence Saint Johns Health Center, Santa Monica
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Ap rekriteFaz 2
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles · 4 mi lwen
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Ap rekriteFaz 3
- Tower Cancer Research Foundation, Beverly Hills · 6 mi lwen
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
Ap rekriteFaz 1/2
- Research Site, Encino · 10 mi lwen
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Sarcoma Oncology Center, Santa Monica
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Ap rekriteFaz 3
- Tower Cancer Research Foundation, Beverly Hills · 6 mi lwen
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11 mi lwen
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12 mi lwen
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
Ap rekriteFaz 1
- University of California, Los Angeles, Santa Monica
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Ap rekriteFaz 4
- Providence Saint Johns Health Ctr, Santa Monica
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Ap rekriteFaz 2/3
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles · 4 mi lwen
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
Ap rekriteFaz 2Volontè an sante akeyi
- VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles · 4 mi lwen
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Research Site 128, Santa Monica
Etid Kansè pwostat nan lòt vil
- New York City, NY103 etid
- Houston, TX76 etid
- Los Angeles, CA61 etid
- Boston, MA59 etid
- St. Louis, MO46 etid
- Chicago, IL45 etid
- San Francisco, CA45 etid
- Philadelphia, PA44 etid
- Baltimore, MD43 etid
- Nashville, TN43 etid
- Seattle, WA42 etid
- Washington, DC38 etid
Lòt etid nan Santa Monica
- Kansè Poumon ki pa ti selil45 etid
- Kansè nan tete28 etid
- Kansè kolorektal23 etid
- Kansè (tout kalite)22 etid
- Kansè Metastatik19 etid
- Kansè poumon15 etid
- Kansè ovè15 etid
- Karsinòm selil skuamèz tèt ak kou13 etid
- Ensifizyans kadyak11 etid
- Kansè Endomèt10 etid
- Kansè lestomak9 etid
- Kansè pankreyas9 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.